Therapies at the Longevity Centers

Therapy selection follows a comprehensive testing phase. New patients begin with an intake that includes expanded biomarker panels, hormone analysis, nutrient testing, and any specialty panels relevant to their presenting symptoms. The clinical team uses these results to identify specific biological imbalances or deficiencies underlying each patient’s complaints, and therapy is selected on that basis.

Intravenous and infusion-based therapies deliver therapeutic compounds directly into the bloodstream, where they are immediately available at the cellular level. Oral supplementation is subject to absorption variability in the gastrointestinal tract, liver metabolism, and other factors that reduce the proportion of a compound that ultimately reaches target tissues. For patients with nutrient depletion, systemic inflammation, or toxic burden, IV delivery can allow for higher therapeutic concentrations and more consistent physiological outcomes than oral dosing alone.

Regenerative injection therapies—including PRP therapy, prolotherapy, tissue allograft therapy, and NanoScope injections—can be used to address underlying conditions that lead to chronic joint pain, soft-tissue degeneration, tendon and ligament injury, and localized inflammatory conditions. Specialized injection protocols are also available for thyroid support and tinnitus. These therapies are not intended to replace surgical or other medical interventions in all clinical scenarios, but they provide an alternative for patients who would prefer to avoid or delay surgery, or for whom surgery is not available.

This category encompasses the hormonal and cellular protocols used to address age-related biological decline. It includes bioidentical hormone optimization for men and women, peptide signaling therapy, VSEL-based anti-aging therapies, longevity-focused IV ozone therapy, medical lymphatic drainage therapy, PEMF therapy, and NAD electrophoresis patches. Therapy selection is based on each patient’s diagnostic panel rather than a standardized program.

Hormonal imbalance is among the most common and most frequently overlooked contributors to cognitive and emotional symptoms. Declining or dysregulated levels of testosterone, estrogen, progesterone, and thyroid hormones can each contribute to persistent fatigue, brain fog, mood instability, reduced motivation, and disrupted sleep. Hormone optimization therapy and hormone testing is therefore offered within both the Longevity & Preventative Medicine and Mental Wellness categories, reflecting the clinical interconnection between hormonal and neurological health.

Available fertility-focused therapies include ovarian regenerative therapy using PRP, VSEL therapy, enclomiphene therapy for male hormonal and reproductive support, EBOO therapy for reducing oxidative and inflammatory burden on reproductive tissue, and a Comprehensive Fertility Optimization Program. These protocols are generally appropriate for patients who have undergone standard fertility evaluation and are seeking to address underlying physiological factors that may not have been identified, or as an adjunct to existing reproductive endocrinology care.

Supportive Oligonucleotide Technique (SOT) is an RNA-based therapy in which a custom oligonucleotide—derived from genetic material isolated from the patient’s own blood sample—is designed to interfere with the gene expression of a specific pathogen. In the context of chronic Lyme disease and its co-infections, SOT targets the mechanisms by which these pathogens evade the immune system and sustain infection. Each protocol is individualized to the patient’s confirmed pathogen profile and is administered under the supervision of a Lyme-literate physician who has conducted a thorough clinical and functional evaluation.

Our weight optimization therapies are built around a metabolic evaluation that assesses hormonal status, insulin sensitivity, inflammatory markers, and body composition data before any intervention is selected. This distinguishes the approach from conventional programs, which often begin with a prescriptive medication or caloric-reduction protocol without first identifying any physiological factors that may be responsible for a patient’s weight resistance. Depending on what the diagnostic evaluation reveals, protocols may involve GLP-1 metabolic therapy, peptide-based metabolic support, metabolic muscle activation, or systemic chelation—or a combination of these.

No physician referral is required. Patients can schedule online for a diagnostic intake or a Longevity and Wellness Assessment, after which the clinical team will review results and present a recommended therapy plan.